China Anabolic Steroids Powder Manufacturer
EnglishAfrikaansБългарскиNederlandsFrançaisDeutschItaliano日本語LatīnaNorskپارسیPolskiPortuguêsRomânăРусскийSlovenčinaSlovenščinaEspañolSvenskaTürkçeУкраїнськаудмурт кыл

Other Steroids

» Steroids Raw » Other Steroids

  • Specifications
  • Product Description
  • Product Usage
  • COA

Abiraterone
Alias : 17-(3-Pyridyl)androsta-5,16-dien-3beta-ol
CAS: 154229-19-3
Molecular Formula: C24H31NO
Molecular Weight: 349.51
Molecular Structure:
Assay: 99%
Appearance: White powder
Grade: Pharmaceutical Grade
Storage: Shading, confined preservation
Usage: It is indicated for use in combination with prednisone as a treatment for metastatic castration-resistant prostate cancer.

Abiraterone is a drug used in combination with prednisone in metastatic castration-resistant prostate cancer (formerly hormone-resistant or hormone-refractory prostate cancer) -- i.e., prostate cancer not responding to androgen deprivation or treatment with antiandrogens. It is formulated as the prodrug abiraterone acetate and marketed under the trade name Zytiga. Cadila Pharmaceuticals has recently started marketing Abiraterone acetate under the trade name Abretone.

After an expedited six-month review, abiraterone was approved by the U.S. Food and Drug Administration (FDA) in April 2011. In Phase III trials, it extended median survival to 14.8 months versus 10.9 months placebo, and the trial was stopped because of the successful outcome.

It is indicated for use in combination with prednisone as a treatment for metastatic castration-resistant prostate cancer. It has received FDA (28 April 2011), EMA (23 September 2011), MHRA (5 September 2011) and TGA (1 March 2012) approval for this indication. In Australia it is covered by the Pharmaceutical Benefits Scheme when being used to treat castration-resistant prostate cancer and given in combination with prednisone/prednisolone (subject to the conditions that the patient is not currently receiving chemotherapy, is either resistant or intolerant of docetaxel, has a WHO performance status of <2, and his disease has not since become progressive since treatment with PBS-subsidised abiraterone has commenced).

Items Specifications Results
Appearance A White or almost white crystalline powder white powder
Solubility Freely soluble in methylene chloride,acetone and in THF,hardly soluble in n-Heptane Conform
Identification A).By IR: Positive Conform
B).By HPLC: Positive Conform
Specific Rotation -370to -450 -420
Residue on ignition 0.2% max 0.07%
Loss on drying 1.0% max 0.22%
Heavy metals 20ppm max Conform
Related Substance
(by HPLC)
Unspecified impurity: 0.1% max 0.08%
Total impurities: 0.5% max 0.33%
Residual solvents Methanol:3000ug/g max 1160
Methylene chloride: 600ug/g max Not detected
THF: 720ug/g max Not detected
Acetic acid:5000ug/g max Not detected
Storage condition Preserve in tight,light-resistant contaners,and store at room temperatura.
Assay (on anhydrous basis) 98.0% to 102.0% 99.7%

Enquiry Form ( we will get back you as soon as possible )

Name:
*
Email:
*
Message:

Verification:
5 + 6 = ?

Maybe you like also

  • Our Advantage

    Good Price

    High Quality

    Fast Delivery

    Safe Shipment

    Excellent After-sale Service

  • Local Warehouse

    EU Warehouse

    UK Warehouse

    USA Warehouse

    Canada Warehouse

    Australia Warehouse

  • Payment Method

    Paypal

    Bitcoin

    Bank Wire

    Money Gram

    Western Union

  • Contact Us

    Email: jacob@steroid-peptide.com

    WhatsApp: +8615636286252

    Phone: 0086-15636286252

    Website: www.steroid-peptide.com

    Welcome your inquiry